A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

Conditions: Thyroid Eye Disease
Interventions: Drug: Teprotumumab
Sponsors: Horizon Therapeutics USA, Inc.
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 30, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments